Stanford University
Showing 12,701-12,710 of 34,968 Results
-
Roger Howe
William E. Ayer Professor of Electrical Engineering, Emeritus
BioDesign and fabrication of sensors and actuators using micro and nanotechnologies, with applications to information processing and energy conversion.
-
Kurt Howerton
Director & CIO, School of Engineering
Current Role at StanfordDirector of Information Technology, School of Engineering
-
Brooke Howitt
Irene Adler Professor
BioDr. Howitt is a gynecologic and sarcoma pathologist, with academic interests in gynecologic mesenchymal tumors and morphologic and clinical correlates of molecular alterations in gynecologic neoplasia.
-
Michael R. Howitt
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur lab is broadly interested in how intestinal microbes shape our immune system to promote both health and disease. Recently we discovered that a type of intestinal epithelial cell, called tuft cells, act as sentinels stationed along the lining of the gut. Tuft cells respond to microbes, including parasites, to initiate type 2 immunity, remodel the epithelium, and alter gut physiology. Surprisingly, these changes to the intestine rely on the same chemosensory pathway found in oral taste cells. Currently, we aim to 1) elucidate the role of specific tuft cell receptors in microbial detection. 2) To understand how protozoa and bacteria within the microbiota impact host immunity. 3) Discover how tuft cells modulate surrounding cells and tissue.
-
Anna Howley
Ph.D. Student in Immunology, admitted Autumn 2024
BioAnia Howley is an Immunology PhD student. She received her BS in Biology from College of the Holy Cross in 2022, where she investigated the function of APOBEC3G variants in the context of HIV infection. After completing her degree, she joined the Wyss Institute for Biologically Inspired Engineering at Harvard University. Using an organ-on-chip model, she studied the effects of radiation-induced injury on human bone marrow and developed an in-vitro model of Shwachman Diamond Syndrome using shRNA-based knockdown in primary CD34+ progenitor cells.
